Clinical Trial Update: Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating hepatic arterial infusion of floxuridine, gemcitabine, and radiolabeled monoclonal antibody for liver metastases from colorectal canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Liver Metastases
• Rectal Cancer

Drugs mentioned

• Floxuridine (floxuridine)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: City of Hope Medical Center | Conditions: Liver Metastases, Recurrent Colon Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-28